Caribou Biosciences (Nasdaq: CRBU), whose co-founders include Jennifer Doudna, PhD, capped a one-year 83% freefall of its stock after announcing plans to evaluate strategic alternatives, as investors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results